Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-13 6:17 pm Purchase |
2024-12-31 | 13G | MaxCyte, Inc. MXCT |
CADIAN CAPITAL MANAGEMENT LP | 9,344,424 8.900% |
1,155,476 (+14.11%) |
Filing History |
| 2025-02-05 5:28 pm Sale |
2024-12-31 | 13G | MaxCyte, Inc. MXCT |
BLACKROCK INC BLK |
8,256,000 7.800% |
-2,169,244 (-20.81%) |
Filing History |
| 2024-11-13 7:14 pm Purchase |
2024-09-30 | 13G | MaxCyte, Inc. MXCT |
CADIAN CAPITAL MANAGEMENT LP | 8,188,948 7.800% |
2,544,050 (+45.07%) |
Filing History |
| 2024-11-08 5:31 pm Unchanged |
2024-09-30 | 13G | MaxCyte, Inc. MXCT |
BLACKROCK INC BLK |
10,425,244 9.900% |
0 (Unchanged) |
Filing History |
| 2024-10-31 4:23 pm Sale |
2024-09-30 | 13G | MaxCyte, Inc. MXCT |
Integrated Core Strategies (US) LLC | 4,192,865 4.000% |
-1,556,150 (-27.07%) |
Filing History |
| 2024-10-21 4:11 pm Purchase |
2024-09-30 | 13G | MaxCyte, Inc. MXCT |
BLACKROCK INC BLK |
10,425,244 9.900% |
2,160,311 (+26.14%) |
Filing History |
| 2024-03-25 4:36 pm Purchase |
2024-03-19 | 13G | MaxCyte, Inc. MXCT |
Integrated Core Strategies (US) LLC | 5,749,015 5.500% |
736,732 (+14.70%) |
Filing History |
| 2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | MaxCyte, Inc. MXCT |
Casdin Capital, LLC | 0 0.000% |
-9,220,000 (Position Closed) |
Filing History |
| 2024-02-14 12:25 pm Purchase |
2023-12-31 | 13G | MaxCyte, Inc. MXCT |
CADIAN CAPITAL MANAGEMENT LP | 5,644,898 5.500% |
5,644,898 (New Position) |
Filing History |
| 2024-02-13 5:09 pm Purchase |
2023-12-29 | 13G | MaxCyte, Inc. MXCT |
The Vanguard Group | 5,282,108 5.090% |
5,282,108 (New Position) |
Filing History |
| 2024-02-01 4:25 pm Sale |
2023-12-31 | 13G | MaxCyte, Inc. MXCT |
Integrated Core Strategies (US) LLC | 5,012,283 4.800% |
-758,611 (-13.15%) |
Filing History |
| 2024-01-26 11:49 am Purchase |
2023-12-31 | 13G | MaxCyte, Inc. MXCT |
BLACKROCK INC BLK |
8,264,933 8.000% |
531,720 (+6.88%) |
Filing History |
| 2023-11-17 4:05 pm Purchase |
2023-11-08 | 13G | MaxCyte, Inc. MXCT |
Integrated Core Strategies (US) LLC | 5,770,894 5.600% |
5,770,894 (New Position) |
Filing History |
| 2023-02-14 10:15 am Sale |
2023-02-14 | 13G | MaxCyte, Inc. MXCT |
BAMCO INC | 2,182,982 2.140% |
-2,948,852 (-57.46%) |
Filing History |
| 2023-02-13 2:08 pm Sale |
2022-12-31 | 13G | MaxCyte, Inc. MXCT |
Sofinnova Crossover I SLP | 4,610,693 4.500% |
-500,000 (-9.78%) |
Filing History |
| 2023-01-31 1:58 pm Purchase |
2022-12-31 | 13G | MaxCyte, Inc. MXCT |
BLACKROCK INC BLK |
7,733,213 7.600% |
890,253 (+13.01%) |
Filing History |
| 2023-01-10 4:48 pm Sale |
2023-01-05 | 13G | MaxCyte, Inc. MXCT |
Casdin Capital, LLC | 9,220,000 9.020% |
-4,751,334 (-34.01%) |
Filing History |
| 2022-02-15 2:06 pm Purchase |
2022-02-14 | 13G | MaxCyte, Inc. MXCT |
BAMCO INC | 5,131,834 5.070% |
5,131,834 (New Position) |
Filing History |
| 2022-02-11 10:59 am Purchase |
2021-12-31 | 13G | MaxCyte, Inc. MXCT |
Sofinnova Crossover I SLP | 5,110,693 5.100% |
5,110,693 (New Position) |
Filing History |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | MaxCyte, Inc. MXCT |
BLACKROCK INC BLK |
6,842,960 6.800% |
6,842,960 (New Position) |
Filing History |